Scientific Programme

Birmingham, United Kingdom

12–13 October 2026

Monday 12 October

Presentations are each followed by up to 2 min for any immediate queries, with discussion at the end of each session.

K = Keynote: 12 min (10 + 2) O = Oral: 10 min (8 + 2) PO = Poster-Oral: 5 min (3 + 2) D = Discussion

Time	Type	Session & speaker	Country	Title
09:00		Jason Gardosi	UK	Welcome
09:05		Session 1		Artificial Intelligence and fetal growth assessment
	K	Asma Khalil	UK	Artificial Intelligence in fetal biometry and risk assessment: from innovation to clinical implementation
	O	Daniele Di Mascio	IT	Maternal and antenatal Telehealth through wearables and impact on pregnancy outcomes
	D	Panel		Discussion
09:30		Session 2		Fetal growth in twin pregnancy
	K	Nir Melamed		Is it time to introduce twin specific growth charts?
	D	Khalil, Grantz, Gardosi		Plenary with short presentations and Open Forum
10:30		Refreshment Break
11:00		Session 3		Epidemiology
	O	Alice Hocquette	FR	Monitoring changes in small and large-for-gestational age births between 2010 and 2024: A population-based study in 21 European countries
	O	Pierre Gibert	FR	How Is Fetal Growth Restriction Defined in Administrative Healthcare and Claims Databases? A Scoping Review
	O	Felicia Molokoan	ZA	Foetal growth in HIV exposed pregnancies: a longitudinal ultrasound study in South Africa
	O	Wessel Ganzevoort	NL	Unveiling the Later-in-Life Impact of Fetal Growth Restriction Across the Birth Weight Distribution
	PO	Ute Feucht	ZA	Integrating pre- and postnatal growth assessment to better understand stunting in South African infants
	D	Panel		Discussion
12:00		Session 4		Fetal Growth Charts
	K	Jason Gardosi	UK	Comparative analysis of fetal weight charts in screen positive rate and prediction of pregnancy outcome
	O	Helen Mulol	ZA	Maternal and Socioeconomic Factors Explain Deviations From INTERGROWTH-21st Growth Standards in South Africa
	O	Elodie Logodin	FR	False Positives Resulting from Prenatal Screening and Maternal Wellbeing and Mental Health: A French Population-Based Study
	O	Manouk Hendrix	NL	Delphi Consensus Definition of Fetal Growth Restriction: Identifying Fetuses at Risk of Neonatal Morbidity
	D	Panel		Discussion
13:00		Lunch
14:00		Session 5		Ultrasound scans: Accuracy and Quality Assurance
	PO	Anouk M.C. Roestenburg	NL	Performance of the Hadlock Formula in the Prediction of Fetal Size in Third Trimester SGA Fetuses with and without FGR
	PO	Victoria Bishop	UK	Implementing the BMUS Two-Diameter Calculated Circumference Method for Fetal Biometry
	PO	Autanza Badcock-Scruton	UK	Reduced Growth Velocity: Quality Control of Fetal Growth Ultrasound
	PO	Pallavi Koutikwar	UK	Detection and Management of Fetal Growth Restriction: A Clinical Audit
	PO	Laith Al-Dwaikat	UK	Accuracy of SFH and USS in detection SGA
	D	TBC		Comment on Quality Assurance
14:30		Session 6		Routine 3T Scan
	K	Laurence Impey	UK	Universal late 3rd trimester scanning and stillbirth prevention
	O	Ramesh Ganapathy	UK	Impact of a routine third trimester scan - a 5 year experience in a London teaching hospital
	PO	Anneka Ali	UK	Clinical utility of third-trimester ultrasound for fetal growth surveillance: accuracy, predictors of scan performance and implications for SGA
	PO	Oliver Hugh	UK	SGA detection rates of routine 3T ultrasound vs serial fundal height measurement in low risk pregnancies
	D	Panel		Discussion
15:15		Session 7		3-D Ultrasound
	K	Katie Grantz	USA	First trimester three-dimensional ultrasound measures and adverse pregnancy outcomes
	PO	Katie Grantz	USA	Fetal body composition and organ volumes by parity: NICHD fetal 3-D studies
	D	Panel		Discussion
15:30		Refreshment Break
15:45		Session 8		Growth Velocity
	O	Cindy Dennis	UK	Fetal Growth Velocity and the Missed Majority: A Proportional Centile-Drop Framework
	O	Elena D’Alberti	UK	Timing of Abnormal Growth Velocity and Risk of Adverse Neonatal Outcome: A Longitudinal Cohort Study
	O	Oliver Hugh	UK	GROW centiles help identify growth restriction in babies that are not SGA in the third trimester
	O	Eva Meler	ES	Added value of EFW growth velocity to Doppler evaluation for the prediction of perinatal outcomes among fetuses with EFW<10th centile at term
	D	Panel		Discussion
16:35		Session 9		Clinical Audit
	PO	Adalina Sacco	UK	“Missed” FGR: is it really all about scanning?
	PO	Hannah Taylor	UK	Lessons from missed case audit in the UK national health service
	PO	Amanda Merricks	UK	Digital growth charts: development of a Power BI dashboard to support real-time monitoring of growth alerts during pregnancy
	PO	Gemma Horsefield	UK	Impact of a dedicated Perinatal Institute GAP GROW clinic on fetal growth assessment and perinatal outcomes in pregnant smokers
	D	Discussion
17:00		Session 10		Outcome and Prevention
	K	Nuzhat Aziz	IN	Small For Gestational Age Stillbirth Characteristics from 101,550 Births in Southern India: Lessons for prevention
	O	Hanna Ellson	UK	Reduction in stillbirth rates following transition from paper-based to digital growth charts in England: interrupted time-series analysis
	O	Holly Baker	NZ	Impact of the Introduction of the Growth Assessment Protocol (GAP) at Counties Manukau Health on SGA and Perinatal Mortality
	O	Emily Butler	UK/NZ	GAP NZ: First results of implementation of GROW 2.0 digital charts as a national program
	D	Panel		Discussion
18:00		Close
20:00		Gala Dinner & Dance

Tuesday 13 October

Presentations are each followed by up to 2 min for any immediate queries, with discussion at the end of each session.

K = Keynote: 12 min (10 + 2) O = Oral: 10 min (8 + 2) PO = Poster-Oral: 5 min (3 + 2) D = Discussion

Time	Type	Session & speaker	Country	Title
08:00		Francesc Figueras	ES	Welcome
08:05		Session 11		Prediction of risk
	O	G. Auriemma	IT/UK	Characteristics and outcomes of pregnancies with extreme mid-pregnancy uterine artery indices
	PO	Ricardo Ciammella	AR	Fetal growth restriction prevention with aspirin in patients at low risk of preeclampsia in first-trimester screening
	D	Panel		Discussion
08:30		Session 12		Placenta
	O	Manouk Hendrix	NL	Impact of multiple placental maternal vascular malperfusion lesions on fetal growth, angiogenic biomarkers and neonatal adverse outcomes
	PO	Manouk Hendrix	NL	From placenta to patient: the impact of multiple maternal vascular malperfusion (MVM) lesions on neonatal health
	D	Panel		Discussion
08:50		Session 13		Biochemical markers
	O	Francesc Figueras	ES	Angiogenic factors in FGR
	PO	Javier Caradeux	CL	Performance of sFlt-1/PlGF ratio for the prediction of severe preeclampsia in women diagnosed with preeclampsia without severe features
	PO	Neeta Singh	IN	Association of maternal plasma soluble neuropilin levels in early-onset fetal growth restriction compared with normally grown fetuses
	PO	V Chacon-Quintero	NL	Biomarker potential of microRNAs in maternal circulation for fetal growth restriction and small for gestational age
	D	Panel		Discussion
09:30		Session 14		MRI
	O	Liran Hiersch	IL	Predicting adverse perinatal outcomes in small-for-gestational-age fetuses using MRI
	O	Hadi Waheed	UK	Antenatal MRI better predicts birthweight centile compared with ultrasound, especially in macrosomic fetuses
	PO	Gabor Szloboda	UK	Diagnostic utility of fetal MRI in isolated ventriculomegaly: a comparative analysis of early vs. late gestational detection
	D	Panel		Discussion
10:00		Refreshment Break
10:30		Session 15		Early-onset FGR
	K	Wessel Ganzevoort	NL	Early-onset FGR
	O	M.E. Bruins	NL	Early-onset FGR and presumed uteroplacental insufficiency: insights into unexpected congenital and chromosomal anomalies
	O	M.E. Bruins	NL	Short-term outcomes of maternal phosphodiesterase type 5 inhibitors for fetal growth restriction
	O	Edurne Mazarico	ES	Effect of low-molecular-weight heparin on neonatal morbidity and umbilical cord blood inflammatory and angiogenic markers
	PO	Büşra Ünlü	NL	Agreement between Doppler cardiotocography and fetal ECG cardiotocography for short-term variation assessment
	D	Panel		Discussion
11:45		Session 16		Late-onset FGR
	K	Francesc Figueras	ES	Late-onset FGR
	K	Christoph Lees	UK	Results of Truffle 2: implication for timing of delivery
	O	Ute Feucht	ZA	Umbiflow umbilical artery Doppler as an affordable, accessible screener for risk of stillbirth and fetal growth restriction
	PO	Gil-Armas César	ES	Neonatal outcomes according to gestational diabetes treatment in pregnancies complicated by a late-onset diagnosis of SGA or FGR
	O	Laura A. Lens	NL	CPR-based management versus care as usual in non-SGA fetuses at term with maternal perceived reduced fetal movements (CEPRA)
	O	José Morales-Roselló	ES/UK	Beyond Categorical Definitions: A Risk-Based Classification of Late-Onset Fetal Growth Disorders
	D	Panel		Discussion
13:00		Lunch
14:00		Session 17		Macrosomia and large for gestational age
	O	Jason Gardosi	UK	New guidelines for management of big babies
	PO	Zita Zsuzsanna Gonda	HU	Is Bigger Better: The Complications of Foetal Macrosomia
	PO	Darya Tobutt	UK	An Investigation of Parental Factors Influencing Neonatal Macrosomia
	D	Panel		Discussion
14:20		Session 18		Consensus vs Evidence: if conflicting, which is best?
	K	Daniele Di Mascio	IT	Consensus and controversies of international FGR guidelines
	K	Sanne Gordijn	NL	Progress with Delphi consensus procedure on fetal growth
	O	Nir Melamed	CA	The need to standardise Doppler reference charts
	O	Jason Gardosi	UK	The need to standardise fetal weight charts
15:00	D	Faculty		Plenary/Open Forum
16:00		Close and Refreshments

Posters

All Posters and Poster-Orals will be on electronic display on both days of the meeting

Poster	First author	Country	Title
P 1	Esmée SE Tabernée Heijtmeijer	NL	Towards real-time monitoring of placental function during labor using Near InfraRed Spectroscopy (NIRS): A study protocol
P 2	Javier Caradeux	CL	Fetal growth restriction associated with uniparental disomy of chromosome 6 [UPD(6)]. A case report
P 3	Luveon Yu On Tang	UK	Data Transformation and Processing to Improve Demographic Variables within a Large Database for Perinatal Outcome Modelling
P 4	José Morales-Roselló	ES/UK	The final cerebroplacental ratio Vertebral artery Doppler may outperform
P 5	José Morales-Roselló	ES	Vertebral artery Doppler may outperform middle cerebral artery Doppler in fetal anemia
P 6	Ricardo Ciammella	AR	Added value of chromosomal microarray analysis in Early Fetal Growth Restriction without structural anomalies
Poster-Oral	First author	Country	Title
Monday 12 October - Conference Day 1
Session 3	Epidemiology
PO 1	Ute Feucht	ZA	Integrating pre- and postnatal growth assessment to better understand stunting in South African infants
Session 5	Ultrasound scans: Accuracy and Quality Assurance
PO 2	Anouk M.C. Roestenburg	NL	Performance of the Hadlock Formula in the Prediction of Fetal Size in Third Trimester SGA Fetuses with and without FGR
PO 3	Victoria Bishop	UK	Implementing the BMUS Two-Diameter Calculated Circumference Method for Fetal Biometry
PO 4	Autanza Badcock-Scruton	UK	Reduced Growth Velocity: Quality Control of Fetal Growth Ultrasound
PO 5	Pallavi Koutikwar	UK	Detection and Management of Fetal Growth Restriction: A Clinical Audit
PO 6	Laith Al-Dwaikat	UK	Accuracy of SFH and USS in detection SGA
Session 6	Routine 3T Scan
PO 7	Anneka Ali	UK	Clinical utility of third-trimester ultrasound for fetal growth surveillance: accuracy, predictors of scan performance and implications for SGA
PO 8	Oliver Hugh	UK	SGA detection rates of routine 3T ultrasound vs serial fundal height measurement in low risk pregnancies
Session 7	3-D Ultrasound
PO 9	Virali Patel	USA	Fetal body composition and organ volumes by parity: NICHD fetal 3-D studies
Session 9	Clinical Audit
PO 10	Adalina Sacco	UK	“Missed” FGR: is it really all about scanning?
PO 11	Hannah Taylor	UK	Lessons from missed case audit in the UK national health service
PO 12	Amanda Merricks	UK	Digital growth charts: development of a Power BI dashboard to support real-time monitoring of growth alerts during pregnancy
PO 13	Gemma Horsefield	UK	Impact of a dedicated Perinatal Institute GAP GROW clinic on fetal growth assessment and perinatal outcomes in pregnant smokers
Tuesday 13 October - Conference Day 2
Session 11	Prediction of risk
PO 14	Ricardo Ciammella	AR	Fetal growth restriction prevention with aspirin in patients at low risk of preeclampsia in first-trimester screening
Session 12	Placenta
PO 15	Manouk Hendrix	NL	From placenta to patient: the impact of multiple maternal vascular malperfusion (MVM) lesions on neonatal health
Session 13	Biochemical markers
PO 16	Javier Caradeux	CL	Performance of sFlt-1/PlGF ratio for the prediction of severe preeclampsia in women diagnosed with preeclampsia without severe features
PO 17	Neeta Singh	IN	Association of maternal plasma soluble neuropilin levels in early-onset fetal growth restriction compared with normally grown fetuses
PO 18	V Chacon-Quintero	NL	Biomarker potential of microRNAs in maternal circulation for fetal growth restriction and small for gestational age
Session 14	MRI
PO 19	Gabor Szloboda	UK	Diagnostic utility of fetal MRI in isolated ventriculomegaly: a comparative analysis of early vs. late gestational detection
Session 15	Early-onset FGR
PO 20	Büşra Ünlü	NL	Agreement between Doppler cardiotocography and fetal ECG cardiotocography for short-term variation assessment
Session 16	Late-onset FGR
PO 21	Gil-Armas César	ES	Neonatal outcomes according to gestational diabetes treatment in pregnancies complicated by a late-onset diagnosis of SGA or FGR
Session 17	Macrosomia and large for gestational age
PO 22	Zita Zsuzsanna Gonda	HU	Is Bigger Better: The Complications of Foetal Macrosomia
PO 23	Darya Tobutt	UK	An Investigation of Parental Factors Influencing Neonatal Macrosomia